乙型肝炎——可预防且现在可治疗。 - Suppr

Hepatitis B--preventable and now treatable.

作者信息

Hoofnagle Jay H

出版信息

N Engl J Med. 2006 Mar 9;354(10):1074-6. doi: 10.1056/NEJMe058309.

DOI:10.1056/NEJMe058309

PMID:16525145

Abstract

摘要

相似文献

Hepatitis B--preventable and now treatable.

N Engl J Med. 2006 Mar 9;354(10):1074-6. doi: 10.1056/NEJMe058309.

[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].

Zhonghua Gan Zang Bing Za Zhi. 2010 Feb;18(2):109-12. doi: 10.3760/cma.j.issn.1007-3418.2010.02.008.

Changing landscape of antiviral resistance management in chronic hepatitis B.

J Gastroenterol Hepatol. 2008 Sep;23(9):1314-7. doi: 10.1111/j.1440-1746.2008.05551.x.

[Comparison of the therapeutical effects of entecavir and lamvudine in treatment of HBeAg-positive chronic hepatitis B].

Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):873-4.

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

N Engl J Med. 2006 Mar 9;354(10):1011-20. doi: 10.1056/NEJMoa051287.

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

N Engl J Med. 2006 Mar 9;354(10):1001-10. doi: 10.1056/NEJMoa051285.

[Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible].

Eksp Klin Gastroenterol. 2007(5):40-5.

[Predictors for virologic response in management of chronic hepatitis B].

Korean J Hepatol. 2010 Mar;16(1):1-4. doi: 10.3350/kjhep.2010.16.1.1.

Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):569-79. doi: 10.1586/14787210.6.5.569.

Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir.

J Clin Gastroenterol. 2010 Oct;44(9):653-7. doi: 10.1097/MCG.0b013e3181d52946.

引用本文的文献

Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.

Infect Dis Ther. 2016 Mar;5(1):53-64. doi: 10.1007/s40121-015-0101-y. Epub 2016 Jan 13.

Recent advances in micro/nanotechnologies for global control of hepatitis B infection.

Biotechnol Adv. 2015 Jan-Feb;33(1):178-190. doi: 10.1016/j.biotechadv.2014.11.003. Epub 2014 Nov 20.

Improving health Professional's knowledge of hepatitis B using cartoon based learning tools: a retrospective analysis of pre and post tests.

BMC Med Educ. 2014 Nov 21;14:244. doi: 10.1186/s12909-014-0244-7.

New perspective on the natural course of chronic HBV infection.

Front Med. 2014 Jun;8(2):129-34. doi: 10.1007/s11684-014-0339-x. Epub 2014 May 29.

Sero-epidemiology of Hepatitis B Surface Antigenaemia among Adult Nigerians with Clinical Features of Liver Diseases Attending a Primary-Care Clinic in a Resource-Constrained Setting of Eastern Nigeria.

N Am J Med Sci. 2013 Apr;5(4):293-300. doi: 10.4103/1947-2714.110441.

DNA-guided hepatitis B treatment, viral load is essential, but not sufficient.

World J Gastroenterol. 2009 Jan 28;15(4):423-30. doi: 10.3748/wjg.15.423.

Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.

J Natl Cancer Inst. 2008 Aug 20;100(16):1121-3. doi: 10.1093/jnci/djn261. Epub 2008 Aug 11.

The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.

Cancer. 2007 May 15;109(10):2100-8. doi: 10.1002/cncr.22642.

Entecavir: a review of its use in chronic hepatitis B.

Drugs. 2006;66(12):1605-22; discussion 1623-4. doi: 10.2165/00003495-200666120-00009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hepatitis B--preventable and now treatable.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献